|
Name |
1-Tetracosanol
|
Molecular Formula | C24H50O | |
IUPAC Name* |
tetracosan-1-ol
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCO
|
|
InChI |
InChI=1S/C24H50O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25/h25H,2-24H2,1H3
|
|
InChIKey |
TYWMIZZBOVGFOV-UHFFFAOYSA-N
|
|
Synonyms |
1-Tetracosanol; Tetracosanol; 506-51-4; LIGNOCERYL ALCOHOL; Tetracosan-1-ol; n-Tetracosanol; Lignocerol; Tetracosyl alcohol; Lignoceric alcohol; n-Tetracosanol-1; 2N0PI37IOC; NSC-93768; 1-Tetracosanol 10 microg/mL in Methyl-tert-butyl ether; HSDB 5674; EINECS 208-043-9; NSC 93768; UNII-2N0PI37IOC; MFCD00042662; EC 208-043-9; SCHEMBL17228; DTXSID8027161; CHEBI:77413; LIGNOCERYL ALCOHOL [HSDB]; NSC93768; LMFA05000222; ZINC59724995; AKOS015839851; AS-56560; Lignoceryl alcohol, >=99% (capillary GC); FT-0608310; T0593; T72542; Q2806593; W-105938; TETRACOSANOL (CONSTITUENT OF SAW PALMETTO) [DSC]
|
|
CAS | 506-51-4 | |
PubChem CID | 10472 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 354.7 | ALogp: | 11.6 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 22 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 25 | QED Weighted: | 0.176 |
Caco-2 Permeability: | -5.166 | MDCK Permeability: | 0.00000584 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.06 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.01 | Plasma Protein Binding (PPB): | 97.69% |
Volume Distribution (VD): | 3.94 | Fu: | 1.20% |
CYP1A2-inhibitor: | 0.076 | CYP1A2-substrate: | 0.151 |
CYP2C19-inhibitor: | 0.15 | CYP2C19-substrate: | 0.047 |
CYP2C9-inhibitor: | 0.039 | CYP2C9-substrate: | 0.964 |
CYP2D6-inhibitor: | 0.12 | CYP2D6-substrate: | 0.021 |
CYP3A4-inhibitor: | 0.152 | CYP3A4-substrate: | 0.018 |
Clearance (CL): | 5.003 | Half-life (T1/2): | 0.035 |
hERG Blockers: | 0.409 | Human Hepatotoxicity (H-HT): | 0.007 |
Drug-inuced Liver Injury (DILI): | 0.161 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.016 |
Skin Sensitization: | 0.973 | Carcinogencity: | 0.024 |
Eye Corrosion: | 0.995 | Eye Irritation: | 0.917 |
Respiratory Toxicity: | 0.43 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000449 | 0.918 | D00AOJ | 0.918 | ||||
ENC000716 | 0.890 | D07ILQ | 0.529 | ||||
ENC000761 | 0.877 | D00STJ | 0.496 | ||||
ENC000433 | 0.872 | D00FGR | 0.451 | ||||
ENC000358 | 0.841 | D0Z5SM | 0.427 | ||||
ENC000434 | 0.840 | D0O1PH | 0.404 | ||||
ENC000591 | 0.840 | D05ATI | 0.364 | ||||
ENC000431 | 0.836 | D05ZPL | 0.326 | ||||
ENC000446 | 0.833 | D0Z1QC | 0.314 | ||||
ENC000915 | 0.819 | D0T9TJ | 0.305 |